| 1 |
Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
Miranda Cooper, H. Kilvert, Paul Hodgkins et al. · CNS Drugs
Open access |
Oct 2019 |
192 |
| 2 |
Estimated Effects of Different Alcohol Taxation and Price Policies on Health Inequalities: A Mathematical Modelling Study
Petra Sylvia Meier, John Holmes, Colin Angus et al. · PLoS Medicine
Open access |
23 Feb 2016 |
166 |
| 3 |
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries
Ashok Kumar Jha, Alex Upton, W. Dunlop et al. · Advances in Therapy
Open access |
Aug 2015 |
147 |
| 4 |
A Framework for Developing the Structure of Public Health Economic Models
Hazel Squires, James B. Chilcott, Ronald L. Akehurst et al. · Value in Health
Open access |
30 Apr 2016 |
126 |
| 5 |
Variation in Health Technology Assessment and Reimbursement Processes in Europe
Ronald L. Akehurst, Eric C. Abadie, Noël Renaudin et al. · Value in Health
Open access |
3 Nov 2016 |
124 |
| 6 |
Estimating under‐ and over‐reporting of drinking in national surveys of alcohol consumption: identification of consistent biases across four English‐speaking countries
Tim R. Stockwell, Jinhui Zhao, Thomas K. Greenfield et al. · Addiction
Open access |
7 Mar 2016 |
122 |
| 7 |
Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models
Anthony James Hatswell, Ash Bullement, Andrew H. Briggs et al. · PharmacoEconomics
|
27 Jul 2018 |
117 |
| 8 |
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia
Rebecca C. Harvey, Anthony James, Gemma Shields · CNS Drugs
Review |
2016 |
113 |
| 9 |
Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF
Vivek Yerrapu Reddy, Ronald L. Akehurst, Shannon O. Armstrong et al. · Journal of the American College of Cardiology
Open access |
23 Nov 2015 |
99 |
| 10 |
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review
Sarah E. Mitchell, Xiaoyan Li, Matthew Woods et al. · Journal of Oncology Pharmacy Practice
Review |
15 Jan 2016 |
70 |
| 11 |
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study
Ash Bullement, Nicholas R. Latimer, Helen Bell‐Gorrod · Value in Health
Open access |
13 Dec 2018 |
69 |
| 12 |
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
Anthony J. Batty, Ryan N. Hansen, Lisa M. Bloudek et al. · Journal of Medical Economics
Open access |
7 May 2013 |
67 |
| 13 |
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models
W. Dunlop, Nicola Mason, James Kenworthy et al. · PharmacoEconomics
Open access |
7 Dec 2016 |
65 |
| 14 |
A Systematic Review of the Economic and Humanistic Burden of Gout
Gemma Shields, Stephen M. Beard · PharmacoEconomics
Review |
12 May 2015 |
65 |
| 15 |
Transparency in Decision Modelling: What, Why, Who and How?
Chris Sampson, Renée J.G. Arnold, Stirling Bryan et al. · PharmacoEconomics
Open access |
26 Jun 2019 |
62 |
| 16 |
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
Vivek Yerrapu Reddy, Ronald L. Akehurst, Shannon O. Armstrong et al. · EP Europace
Open access |
2 Feb 2016 |
52 |
| 17 |
A systematic literature review of the key challenges for developing the structure of public health economic models
Hazel Squires, James B. Chilcott, Ronald L. Akehurst et al. · International Journal of Public Health
ReviewOpen access |
8 Jan 2016 |
52 |
| 18 |
Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death
Anthony James Hatswell, Becky Pennington, L. Pericleous et al. · Health and Quality of Life Outcomes
Open access |
9 Sep 2014 |
49 |
| 19 |
Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Vivek Yerrapu Reddy, Ronald L. Akehurst, Stacey L. Amorosi et al. · Stroke
Open access |
8 May 2018 |
45 |
| 20 |
The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model
Philippe Laramée, Thor‐Henrik Brodtkorb, Nora Rahhali et al. · BMJ Open
Open access |
Sep 2014 |
44 |
| 21 |
Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine
Neil Roskell, Juliana Setyawan, Evelina A. Zimovetz et al. · Current Medical Research and Opinion
Open access |
14 Mar 2014 |
42 |
| 22 |
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands
Marieke Schurer, Suzette M. Matthijsse, Carla Y. Vossen et al. · Value in Health
Open access |
Dec 2021 |
41 |
| 23 |
Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis
Helen Anne van der Nelson, Tim J Draycott, Dimitrios M. Siassakos et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology
Open access |
5 Jan 2017 |
40 |
| 24 |
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer
Elizabeth Thurgar, Mark Gouldson, Suzette M. Matthijsse et al. · Journal of Medical Economics
Open access |
2021 |
38 |
| 25 |
The Cost Effectiveness of Licensed Oromucosal Midazolam (Buccolam®) for the Treatment of Children Experiencing Acute Epileptic Seizures: An Approach When Trial Evidence is Limited
Dawn Lee, Daniel Gladwell, Anthony J. Batty et al. · Pediatric Drugs
|
19 Mar 2013 |
36 |
| 26 |
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States
Raquel Aguiar‐Ibáñez, Chloë Hardern, Frank van Hees et al. · Journal of Medical Economics
Open access |
21 Feb 2022 |
35 |
| 27 |
A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies
Caroline Mary Vass, Niall Davison, Geert Vander Stichele et al. · Patient
Open access |
30 Sep 2019 |
34 |
| 28 |
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Yang Meng, Nadine Hertel, J. Ellis et al. · The European Journal of Health Economics
Open access |
9 Mar 2018 |
33 |
| 29 |
Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
Dawn Lee, Koo Wilson, Ron L Akehurst et al. · Heart
Open access |
3 Jul 2014 |
33 |
| 30 |
Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results
Becky Pennington, Sarah Davis · Value in Health
Open access |
Dec 2014 |
33 |
| 31 |
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK
Georgia Hollier-Hann, Alistair S. Curry, Kateryna Onishchenko et al. · Journal of Medical Economics
Open access |
3 Oct 2019 |
32 |
| 32 |
The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands
Ronald L. Akehurst, N.J. Brereton, Rinat Ariely et al. · Journal of Medical Economics
Open access |
2011 |
32 |
| 33 |
Elucidation of the removal of trivalent and divalent heavy metal ions from aqueous solutions using hybrid-porous composite ion-exchangers by nonlinear regression
Sama Mohammed Al-Jubouri, Sirhan Al‐Batty, Rachel Ramsden et al. · Desalination and Water Treatment
Open access |
Oct 2021 |
31 |
| 34 |
Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1–positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States
Oliver Hale, Karl W. Patterson, Yizhen Lai et al. · Clinical Genitourinary Cancer
Open access |
16 Jul 2020 |
30 |
| 35 |
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy
Karl W. Patterson, Vimalanand S. Prabhu, Ruifeng Xu et al. · European Urology Oncology
Open access |
8 Nov 2018 |
30 |
| 36 |
Cost-effectiveness of Trifluridine/tipiracil for Previously Treated Metastatic Colorectal Cancer in England and Wales
Ash Bullement, Stuart Underhill, Ronan Fougeray et al. · Clinical Colorectal Cancer
Open access |
28 Sep 2017 |
29 |
| 37 |
Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer
Emily-Ruth Marriott, Guy van Hazel, Peter Gibbs et al. · Journal of Medical Economics
Open access |
27 Sep 2016 |
29 |
| 38 |
The impact of home parenteral nutrition on the burden of disease including morbidity, mortality and rate of hospitalisations
Sorrel T. Burden, Matthew Hemstock, Michael Taylor et al. · Clinical Nutrition ESPEN
Open access |
14 Aug 2018 |
28 |
| 39 |
Cost Effectiveness of Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in Ireland
Dawn Lee, Patrick Thornton, Alexander Hirst et al. · Applied Health Economics and Health Policy
Open access |
15 Jul 2013 |
28 |
| 40 |
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
Nermina Ferizović, Jessica J. Summers, Igor Beitia Ortiz de Zárate et al. · PLoS ONE
Open access |
25 Mar 2022 |
27 |
| 41 |
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Ash Bullement, Paul Nathan, Anna Willis et al. · PharmacoEconomics - Open
Open access |
24 Jan 2019 |
27 |
| 42 |
A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?
Ash Bullement, Yang Meng, Miranda Cooper et al. · Journal of Medical Economics
Open access |
14 Nov 2018 |
26 |
| 43 |
Effect of rescue medication on seizure duration in non-institutionalized children with epilepsy
Federico Vigevano, Fenella Jane Kirkham, Bernd Wilken et al. · European Journal of Paediatric Neurology
Open access |
2 Aug 2017 |
26 |
| 44 |
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
Paul E. Emery, Marjolijn van Keep, Steve Beard et al. · PharmacoEconomics
Open access |
24 May 2018 |
25 |
| 45 |
Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine
Alexander Hirst, Chris Knight, Matt Hirst et al. · The European Journal of Health Economics
Open access |
11 Apr 2015 |
25 |
| 46 |
Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the UK
Daniel Gladwell, Tristan Henry, Mark Cook et al. · Applied Health Economics and Health Policy
|
2 Aug 2014 |
25 |
| 47 |
The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial
N.J. Brereton, Bryan J. Winn, Ronald L. Akehurst · Journal of Medical Economics
Open access |
2012 |
23 |
| 48 |
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM ‐003 trial for pomalidomide plus low‐dose dexamethasone
Gareth John Morgan, Antonio Pierangelo Palumbo, Sujith Dhanasiri et al. · British Journal of Haematology
Open access |
18 Nov 2014 |
23 |
| 49 |
Challenging current views on bile acid diarrhoea and malabsorption
Matthew Kurien, Elizabeth Thurgar, Ashley Gerard Davies et al. · Frontline Gastroenterology
Open access |
29 Jun 2017 |
22 |
| 50 |
A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity
Tim S. Grant, Darren K. Burns, Christopher Kiff et al. · PharmacoEconomics
|
17 Dec 2019 |
21 |